UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): April 24, 2018
 
 
Blonder Tongue Laboratories, Inc.
(Exact Name of registrant as specified in its charter)
 
 
 
Delaware
(State or other jurisdiction of incorporation)
 
 
 
1-14120
(Commission File Number)
 
 
 
52-1611421
(I.R.S. Employer Identification No.)
 
 
One Jake Brown Road, Old Bridge, New Jersey    08857
(Address of principal executive offices)  (Zip Code)
 
 
 
Registrant's telephone number, including area code:  (732) 679-4000
 
 
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

Item 5.02
 
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 24 2018, Blonder Tongue Laboratories, Inc. (the "Company") issued a press release announcing the appointment of Bruce A. Gureck as the Company's Executive Vice President and Chief Operating Officer.

In connection with his employment, Mr. Gureck will receive a base salary of $300,000 per year, and will be eligible to participate in the Company's Executive Officer Salary Bonus Plan, subject to the terms of such plan, as determined by the Compensation Committee of the Board of Directors. He will also receive a signing bonus of  $50,000, payable in installments over time through December 2018.  In addition to the cash compensation and signing bonus, Mr. Gureck will be granted an inducement award (as contemplated by Section 711(a) of the NYSE American Company Guide) of 400,000 shares of restricted common stock of the Company, with 100,000 shares vesting on each of the first four one-year anniversaries of his first day of employment with the Company, subject to accelerated vesting in the event of a change in control of the Company. Such inducement award was not issued pursuant to any of the Company's existing equity incentive plans.  He will also be eligible to participate in other Company benefit plans and programs generally available to Company officers and/or employees.

There are no arrangements or understandings between Mr. Gureck and any other persons, pursuant to which he was appointed as an officer of the Company, no family relationships among any of the directors or executive officers of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

The foregoing summary of the Letter Agreement is qualified in its entirety by reference to the complete text of the Letter Agreement, which is filed as Exhibits 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

A copy of the press release announcing Mr. Gureck's appointment is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01
 
Financial Statements and Exhibits

(d)   Exhibits.  The following exhibit is filed herewith:

Exhibit No.
Description
   
10.1
Letter Agreement between Blonder Tongue Laboratories, Inc. and Bruce A. Gureck.
   
99.1
Press Release dated April 24, 2018.
   
 
 
 
2

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BLONDER TONGUE LABORATORIES, INC.



By: /s/ Eric Skolnik  
Eric Skolnik
Senior Vice President and Chief Financial Officer
Date: April 24, 2018



 
 
 
3

 


EXHIBIT INDEX

Exhibit No.
Description
   
10.1
Letter Agreement between Blonder Tongue Laboratories, Inc. and Bruce A. Gureck.
   
99.1
Press Release dated April 24, 2018.
   

 
 
 
 
4

 
 
EXHIBIT 10.1

 



March 27, 2018

Mr. Bruce A. Gureck
4671 Bocaire Blvd
Boca Raton, FL 33487

Dear Bruce:

On behalf of Blonder Tongue Laboratories, Inc. (the "Company"), I am pleased to offer you employment with our Company.  We look forward to a successful working relationship providing the highest quality of products and services to our customers.

Your compensation, benefits, and other initial employment terms are summarized on the enclosed schedule.

On your first day of employment you should report to Bob Pallé and bring with you evidence of your legal authorization to work in the U.S.  I enclose the Company's Proprietary Information and Inventions Agreement, which you must sign and return prior to your first day of work .

By signing below, you are accepting employment and agreeing to all the terms of this letter and its enclosures, which supersede any prior agreements, representations, or discussions regarding your employment.

We look forward to your joining our team.

Sincerely,

/s/ Eric Skolnik  
Eric Skolnik
Senior Vice President
Accepted and Agreed:

/s/ Bruce A Gureck  
Bruce A. Gureck

Dated:   3/27/18

Enc:        Schedule of Compensation, Benefits, and Other Terms
Proprietary Information and Inventions Agreement
 
 
 
 
 
 
 
 
 
 
1
 


 
SCHEDULE OF COMPENSATION, BENEFITS, AND OTHER TERMS

Expected Start Date:
April 23, 2018 ("Start Date")

Position:
Executive Vice President/Chief Operating Officer
Reports to CEO
Direct Reports - Engineering, Marketing & Sales
You will be based in Old Bridge, NJ

Salary:
$300,000 per year, less taxes and withholdings.

Signing Bonus:
You will be entitled to a signing bonus in the amount of $50,000, payable to you as follows: (i) $10,000 payable on or before the Friday following the Start Date, and (ii) $5,000 per month commencing with May 2018 and continuing thereafter through and including December 2018, subject to being paid in full in the event of the termination of your employment by the Company.

Bonus Plan:
You will be eligible to participate in the Executive Officer Salary Bonus Plan, subject to the terms of the Plan, as determined by the Compensation Committee.

Restricted Stock Award:
You will be granted 400,000 shares of restricted common stock of the Company as of your actual Start Date, which will be in book entry form held in an account in your name at the Company's Transfer Agent, American Stock Transfer, and evidenced by a written grant instrument to be executed as soon as practicable following (but dated as of) the Start Date, subject to the following terms and conditions:
• 100,000 shares shall vest on each of the first four one-year anniversaries of the Start Date, subject to your continued employment with the Company as of each of such anniversaries, with accelerated vesting of all shares granted, upon a change in control of the Company;
• prior to vesting, you will not be permitted to vote unvested shares; as a condition of the grant you will execute and deliver to the Company an irrevocable proxy, coupled with an interest, with respect to the shares, in favor of the Board of Directors of the Company or the Board's designee;
• the shares will be granted to you as an inducement award in accordance with the requirements for such awards set forth in the New York Stock Exchange Listed Company Manual, and not pursuant to any shareholder-approved plan maintained by the Company; as such the shares shall be subject to restrictions pursuant to Rule 144 under the Securities Act of 1933 as well as all other applicable securities laws as a result of your anticipated status as a person subject to Section 16 of the Securities Exchange Act of 1934;
• you may, but need not, make an election under Section 83(b) of the Internal Revenue Code of 1986 with respect to the 400,000 shares within the first 30 days following the Start Date, however such election and the payment by you of any taxes associated with such election will not guaranty that any or all of your shares will vest inasmuch as your employment will remain an employment at will; and
• at such time or times when the Company is required to withhold taxes with respect to any of the shares, you will be required to deliver a sufficient amount of cash to the Company to cover the Company's tax-withholding and depositing obligations, which can, at your request, be accomplished on a cashless basis through withholding of vested shares (but not unvested shares.), subject to your compliance with Section 16 of the Securities Exchange Act.

Relocation Expenses:
None.

Paid Time Off:
You will be eligible for (i) seven (7) vacation days during the remainder of calendar year 2018 and (ii) fifteen (15) vacation days per calendar year for each calendar year thereafter (or such greater number of days to which you may be entitled under the Company's then standard employment policies) and (iii) up to six (6) sick days per year, in addition to Company-paid holidays.

Benefits:
Eligibility to participate in the Company's sponsored group health insurance coverage (medical, dental, vision), life insurance, and long-term disability plan commences on or about the Start Date, but in no event later than the first day of the calendar month following the Start Date.  You will be eligible to participate in the Company's 401(k) plan after six months of employment.

Status:
Full-time employee.  This position is not eligible for overtime as it is exempt from overtime under applicable law.  You will be employed as an at-will employee, meaning either you or the Company can end the employment relationship at any time for any reason or no reason.
 
 
 
 
 
 
 
2

 

Work Location:
You will be based in the Company's Old Bridge, NJ office.  However, your position will involve travel time away from the Company's office from time to time.  Any work-related injuries, even if sustained away from the office, are to be reported to the Company immediately. You must take all necessary and reasonable steps to safeguard the security of both electronic and paper records from unauthorized disclosure or damage, whether on-site or at a remote work location, and follow any applicable information technology or security policies relating thereto.

Company Standards:
As an employee, you will be expected to adhere to the Company's standards of professionalism, loyalty, integrity, honesty, and reliability.  Employment is subject to all of the policies and procedures of the Company, as amended from time to time, including but not limited to the Code of Ethics, the Insider Trading Policy, and the Employee Handbook, copies of which are available upon request for your review. As an executive officer of a public company, you will also be subject to compliance with all applicable federal and state securities laws.

Third Party Agreements:
You represent that you have provided to the Company (or the Company's counsel) copies of any agreements with any current or former employers or other third parties that could restrict your ability to be employed or that limit the manner in which you may be employed.  You further represent that you are not subject to any agreements with any current or former employers or other third parties that prevent you from accepting employment with the Company or performing the duties of your position.  You agree not to bring to the Company or use in performing your duties for the Company any current or former employer or third party confidential or proprietary information or trade secrets. You also agree that you will not conduct yourself in a manner that would be violative of any such agreement with your current or former employers.

The Company has the right to modify the terms referenced herein at any time, consistent with any plan terms and applicable law.  You acknowledge and agree that the Company has not provided you any legal or tax advice and that you have had a reasonable opportunity to consult with your own legal and tax advisors if you so choose.


 
 
 
 
3
 
 
EXHIBIT 99.1
 
 

FOR IMMEDIATE RELEASE:

 
Blonder Tongue Appoints Bruce Gureck as Executive Vice President & Chief Operating Officer

OLD BRIDGE, NJ / April 24, 2018 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR ) announced that effective April 23, 2018, the Company's Board of Directors has appointed Bruce A. Gureck as its Executive Vice President and Chief Operating Officer.

Bruce will report directly to Bob Pallé, the Company's, CEO and President.  Initially, Bruce will focus on the Company's engineering, marketing, and sales activities.  The heads of each of those departments will report directly to Bruce.

Bruce is a degreed engineer and seasoned leader, with significant experience working in the satellite, cable, and telecommunications industries.  Bruce has led successful development, marketing, and sales teams for more than 25 years, building and managing high-growth, high technology, sales and manufacturing organizations.

Immediately prior to joining Blonder Tongue, Bruce served as Chief Technology Officer at Humax, a $1.4 Billion revenues electronics manufacturer, where his responsibilities included defining product direction, developing customer relationships and expansion of that company's presence in existing and new product markets.

Bruce spent 11 years with Pace plc, rising to the level of Chief Product and Strategy Officer, working closely with the CEO to expand their development, sales, and market penetration worldwide.  During his tenure at Pace, Bruce drove acquisitions, product management and engineering efforts, which resulted in a significant positive impact on the company's overall value.  Bruce's tenure culminated with the 2015 sale of Pace to Arris in a $2.1 Billion transaction, at a premium to market of more than 25%.  Bruce remained with Arris, post-acquisition, until 2016.

Prior to his tenure at Pace, Bruce held several other significant leadership positions, including an integral role in the formation and growth of Digital Latin America, a partnership between General Instrument Corporation, Liberty Media and Hicks, Muse, Tate & Furst, preceded by several years with General Instrument Corporation as a Product Manager for digital TV products.

Commenting on Bruce's appointment, CEO and President, Bob Pallé said "We are extremely pleased that Bruce has joined the Blonder Tongue family. Over Bruce's nearly 30-year career in the cable, satellite, and telecom markets, Bruce has proven to be a highly motivated and effective leader, driven to deliver bottom-line results, with a focus on the enhancement of shareholder value."

Regarding his appointment as Chief Operating Officer, Bruce Gureck said "I am proud to be joining a company that has delivered innovative and quality products to the industry for many decades.  It will be exciting to work with the team that built the BT legacy and to become a part of Blonder Tongue's bright future."

In connection with Bruce's appointment as Chief Operating Officer, the Company has granted him an employment inducement award comprised of an aggregate of 400,000 shares of restricted stock, subject to time-based vesting conditions.  One quarter of the aggregate inducement award (100,000 shares) will vest on each of the next four one-year anniversaries after the effective date, April 23, 2018, provided that Bruce remains an active employee of the Company on each such date.  The inducement award contains certain acceleration provisions in the event of a change in control.  The inducement award of shares of restricted stock was made outside of the Company's 2016 Employee Equity Incentive Plan and approved by the Compensation Committee of the Company's Board of Directors in reliance on the employment inducement exception to shareholder approval provided under the NYSE American Company Guide, Section 711(a), which requires public announcement of inducement awards.
 
 
More. . .
 
 

 

About Blonder Tongue

Blonder Tongue Laboratories, Inc. together with R. L. Drake Holdings, LLC - its wholly owned subsidiary - offer customers more than 130 years of combined engineering and manufacturing excellence with solid histories of delivering reliable, quality products.  As a leader in the field of cable television communications, the Company provides system operators and integrators serving the cable, broadcast, satellite, IPTV, institutional and professional video markets with comprehensive solutions for the provision of content contribution, distribution and video delivery to homes and businesses. The Company designs, manufactures, sells and supports an equipment portfolio of standard and high definition digital video solutions, as well as core analog video and high speed data solutions for distribution over coax, fiber and IP networks.  Additional information on the Company and its products can be found at www.blondertongue.com , and www.rldrake.com .
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: The information set forth above includes "forward-looking" statements and accordingly, the cautionary statements contained in Blonder Tongue's Annual Report and Form 10-K for the year ended December 31, 2017.  (See Item 1: Business, Item 1A: Risk Factors, Item 3: Legal Proceedings and Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations), and other filings with the Securities and Exchange Commission are incorporated herein by reference.  The words "believe", "expect", "anticipate", "project", "target", "intend", "plan", "seek", "estimate", "endeavor", "should", "could", "may" and similar expressions are intended to identify forward-looking statements.  In addition, any statements that refer to projections for our future financial performance, our anticipated growth trends in our business and other characterizations of future events or circumstances are forward-looking statements.  Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. Blonder Tongue undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.  Blonder Tongue's actual results may differ from the anticipated results or other expectations expressed in Blonder Tongue's "forward-looking" statements.
Contacts
Eric Skolnik
Chief Financial Officer
eskolnik@blondertongue.com
(732) 679-4000
Robert J. Pallé
Chief Executive Officer & President
bpalle@blondertongue.com
(732) 679-4000
 
 
 
 
 
 
 
 
End